Skip to content

Concordance Between Ultra-low Dose (ULD) and Standard Dose CT Scans in the Search for Traumatic Brain Injury

Concordance Between Ultra-low Dose (ULD) and Conventional Standard Dose CT Scans in the Search for Traumatic Brain Injury at the Emergency Department

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04939688
Acronym
ULD-CRANE
Enrollment
2
Registered
2021-06-25
Start date
2021-06-26
Completion date
2021-07-19
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head Injuries, Closed, Head Injuries, Penetrating

Brief summary

The aim of this research is to evaluate the diagnostic concordance of ultra low-dose and standard dose reconstructed computed tomography acquisitions using the ADMIRE algorithm to search for intracranial lesions - both hemorrhagic and bone lesions - in trauma patients at the emergency department. The study will also evaluate the diagnostic performance of the two protocols, as well as the speed of image reading. For the first time, acquisitions ≤ 10 mGy (lower value than reported in the literature) will be performed with top-of-the-range scanners available in the emergency room to search for intracranial lesions. These scanners are equipped with the latest generation of ADMIRE iterative algorithms.

Detailed description

Head trauma is a common reason for consultation at the casualty department. The CT computed tomography scan is the standard examination leading to rapid patient management (admission to intensive care or neurosurgical management). The prevalence of traumatic lesions, intracranial bleeding or fractures, is estimated at 90% in moderate or severe head trauma patients, justifying the systematic use of a CT scan. X-ray exposure from CT scanners is among the highest (order of May 23, 2019 for the Diagnostic Reference Levels, DRL). Radiation protection principles therefore require continuous optimization of acquisition procedures to ensure the lowest possible dose to the patient whilst maintaining satisfactory image quality for diagnosis. In recent years, technological innovations have been developed to optimize the dose delivered to the scanner, such as iterative reconstructions. Numerous studies on image quality and anthropomorphic phantoms and on cadavers have been performed at the imaging department of Nîmes University Hospital. Subsequently, feasibility studies have been conducted on patients, highlighting the use of the ultra low-dose scanner to detect common pathologies. These studies have made it possible to set up ultra-low dose acquisitions for several pathologies with an effective dose level close to a standard radiographic examination. These ultra low-dose acquisitions are now routinely used in our clinical practice for thoracic, spine, pelvis and proximal femurs, extremities and abdomino-pelvic explorations. In the literature, some studies have explored the feasibility of ultra low-dose acquisitions for ear, nose and throat or skull explorations. Our study is in the context of evaluating ULD acquisitions for skull CT for traumatic intracranial lesions. The study by Corcuera-Solano et al. (2014) showed the feasibility of ULD acquisitions (Scanographic Dose Index in Volume, mean SDVI = 15.5 mGy) compared to standard acquisition (mean SDVI = 48.38 mGy) in the follow-up of a heterogeneous group of patients admitted to the neurosurgical intensive care unit, without evaluating the diagnostic performance of the two acquisitions. In this study, the Siemens scanner used was equipped with a 2nd generation iterative reconstruction algorithm (SAFIRE). A 3rd generation algorithm has since been developed (ADMIRE) allowing an improvement in image texture, thus favoring the use of ultra low-dose acquisition for structures with lower spontaneous contrast such as the encephalon. We believe it would therefore be possible to search for intracranial lesions in trauma patients using ultra low-dose protocols, which should make it possible to reduce the doses delivered to the patient whilst maintaining sufficient image quality for diagnosis.

Interventions

RADIATIONConventional dose AND ultra low-dose CT scanning in the search for cranial lesions

As well as undergoing the usual, conventional radiation dose CT scan, these patients will also undergo ultra low-dose CT scanning in the search for cranial lesions.

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Masking description

All patients will have the benefit of two CT scans : one normal dose and one ultra low-dose. However, the results of scans will be interpreted by two independent radiologists (senior and junior) who do not know whether the scan has been done with the normal, classic dose or with the ultra low-dose protocol.

Intervention model description

All patients requiring investigation of traumatic injuries after moderate or severe head trauma as identified at the emergency department. All patients will receive a standard dose CT scan of the skull according to the usual management, as well as a ULD scan of the same area, performed specifically for the needs of the study, following a pre-established standardized protocol. The center's radiologist will interpret the conventional CT scan in real time for patient diagnosis and management, but this interpretation will not be used in the study. The patient will then be redirected to the emergency department for his or her usual management.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients in an emergency situation with a head trauma requiring a scan, i.e. moderate or severe skull trauma, Group 1 or 2 according to the Brain Trauma Task Force classification (Guidelines for management of severe head injury. J Neurotrauma 2000 ; 17 : 507-11) as described by P. Schoettker et al. 2001). * Patient with an isolated skull trauma or polytraumatized patient including skull trauma. * Patient capable of giving informed consent or for whom a person of confidence or legal representative / family member has given informed consent and signed the consent form on the patient's behalf if the patient has been included in an emergency. * Patients affiliated to or beneficiary of a health insurance scheme. * All adult patients aged 18 or over.

Exclusion criteria

* Patients already taking part in another study for which it is not allowed to participate in other clinical studies. * Patients in an exclusion period determined by another study. * Patients who are pregnant, breastfeeding or about to give birth.

Design outcomes

Primary

MeasureTime frameDescription
Presence of at least one subarachnoid hemorrhage found on the standard dose CT-scanDay 0YES/NO
Presence of at least one subarachnoid hemorrhage found on the ultra low-dose CT-scanDay 0YES/NO
Presence of at least one intraparenchymal hemorrhage found on the ultra low-dose CT-scanDay 0YES/NO
Presence of at least one intraparenchymal hemorrhage found on the standard dose CT-scanDay 0YES/NO
Presence of at least one subdural hematoma found on the ultra low-dose CT-scanDay 0YES/NO
Presence of at least one subdural hematoma found on the standard dose CT-scanDay 0YES/NO
Presence of at least one extradural hematoma found on the standard dose CT-scanDay 0YES/NO
Presence of at least one extradural hematoma found on the ultra low-dose CT-scanDay 0YES/NO

Secondary

MeasureTime frameDescription
D. Presence of at least one intracranial hemorrhagic lesion and presence of at least one bone lesion found on the standard dose CT-scan according to the radiologist.Day 0YES/NO
D. Presence of at least one intracranial hemorrhagic lesion and presence of at least one bone lesion found on the ultra low-dose CT-scan according to the radiologist.Day 0YES/NO
E. Presence of at least one intracranial hemorrhagic lesion and presence of at least one bone lesion found on the standard dose CT-scanDay 0YES/NO
E. Presence of at least one intracranial hemorrhagic lesion and presence of at least one bone lesion found on the ultra low-dose CT-scanDay 0YES/NO
Fi.Radiologist's appreciation of the standard dose CT-scan: image qualityDay 0A scale of 1 - 4 will be used (1 = interpretable, 2 = interpretable despite a slight technical problem (centering, movement, constants) 3 = completely interpretable despite a slight technical problem, 4 = no technical problems)
Fi.Radiologist's appreciation of the ultra low-dose CT-scan: image qualityDay 0A scale of 1 - 4 will be used (1 = interpretable, 2 = interpretable despite a slight technical problem (centering, movement, constants) 3 = completely interpretable despite a slight technical problem, 4 = no technical problems)
Fii.Radiologist's appreciation of the standard dose CT-scan: diagnostic qualityDay 0A scale of 1 - 5 will be used (1 = unacceptable, 2 = sub-optimal, 3 = acceptable, 4 = above average, 5 = excellent)
Fiii.Radiologist's appreciation of the standard dose CT-scan: level of confidenceDay 0A scale of 1 - 5 will be used (1 = very poor, 2 = poor, 3 = moderate, 4 = high, 5 = excellent)
Fiii.Radiologist's appreciation of the ultra low-dose CT-scan: level of confidenceDay 0A scale of 1 - 5 will be used (1 = very poor, 2 = poor, 3 = moderate, 4 = high, 5 = excellent)
G. Total dose of X-rays delivered with the standard dose CT-scan : DLPDay 0DACS (Dose Archiving and Communication System) will be used to measure Dose Length Product (DLP) measured in mGy\*cm
G. Total dose of X-rays delivered with the standard dose CT-scan : CTDIDay 0DACS (Dose Archiving and Communication System) will be used to measure Computed Tomography Dose Index in mGy
G. Total dose of X-rays delivered with the ultra low-dose CT-scan : CTDIDay 0DACS (Dose Archiving and Communication System) will be used to measure Computed Tomography Dose Index in mGy
H. Interpretation time with the standard dose CT-scanDay 0The time taken to interpret the images will be measured in minutes
H. Interpretation time with the ultra low-dose CT-scanDay 0The time taken to interpret the images will be measured in minutes
I. Performance of standard dose CT-scan for polytrauma patients. Presence of at least one intracranial hemorrhagic lesion and presence of at least one bone lesion.Day 0YES/NO
I. Performance of the ultra low-dose CT-scan for patients with skull trauma alone. Presence of at least one intracranial hemorrhagic lesion and presence of at least one bone lesionDay 0YES/NO
I. General performance of the ultra low-dose CT-scan for polytrauma patients: Presence of at least one intracranial hemorrhagic lesion and presence of at least one bone lesionDay 0YES/NO
I. General performance of the standard dose CT-scan for patients with skull trauma alone. Presence of at least one intracranial hemorrhagic lesion and presence of at least one bone lesionDay 0YES/NO
Fii.Radiologist's appreciation of the ultra low-dose CT-scan: diagnostic qualityDay 0A scale of 1 - 5 will be used A scale of 1 - 5 will be used (1 = unacceptable, 2 = sub-optimal, 3 = acceptable, 4 = above average, 5 = excellent)
G. Total dose of X-rays delivered with the ultra low-dose CT-scan : DLPDay 0DACS (Dose Archiving and Communication System) will be used to measure Dose Length Product (DLP) measured in mGy\*cm
A. Presence of at least one bone lesion in the skull, arch or face found on the standard dose CT-scanDay 0YES/NO
A. Presence of at least one bone lesion in the skull, arch or face found on the ultra low-dose CT-scanDay 0YES/NO
B. Presence of at least one intracranial hemorrhagic lesion found on the standard dose CT-scanDay 0YES/NO
B. Presence of at least one intracranial hemorrhagic lesion found on the ultra low-dose CT-scanDay 0YES/NO
C. Presence of at least one cranial bone lesion found on the standard dose CT-scanDay 0YES/NO
C. Presence of at least one cranial bone lesion found on the ultra low-dose CT-scanDay 0YES/NO

Other

MeasureTime frameDescription
Patient's ageDay 0In years
Circumstances of traumaDay 0The circumstances of the trauma will be recorded
Type of traumaDay 0The type of trauma will be recorded
Patient's Body Mass IndexDay 0The patient's Body Mass Index will be calculated by computer according to the patient's weight and height (in Kg/m²)
Patient's heightDay 0In cm
Patient's weightDay 0In kilos

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026